Molecular Docking and Absorption, Distribution, Metabolism, and Excretion (ADME) Analysis: Examining the Binding Modes and Affinities of Myricetin With Insulin Receptor, Glycogen Synthase Kinase, and Glucokinase

• Published in: Curēus (Palo Alto, CA) Vol. 16; no. 2; p. e53810
• Main Authors: Murugan, Ramadurai, Tamil Selvan, Silambarasan, Dharmalingam Jothinathan, Mukesh Kumar, Srinivasan, Guru Prasad, Rajan Renuka, Remya, Prasad, Monisha
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 07.02.2024
• Subjects: Blood-brain barrier; Diabetes; Glucose; Hydrogen bonds; Insulin resistance; Kinases; Ligands; Metabolism; Oxidative stress; Pharmacokinetics; Proteins; Software; United States > US; auto dock; therapeutics; molecular docking; myricetin; diabetes; lipinski
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.53810

Aim By using molecular docking analysis (MDA) to examine its interactions with important regulatory proteins linked to diabetes, such as glycogen synthase kinase 3 beta (GSK3β), insulin receptor (IR), and glucose kinase (GCK), this study seeks to explore the therapeutic potential of myricetin, a naturally occurring flavonoid. Objective The main goal is to determine potential effects on insulin signalling, GSK3β activity, and glucose metabolism by evaluating the binding affinities of myricetin with GCK, IR, and GSK3β through MDA. In order to assess the drug affinity of myricetin, the study also intends to perform absorption, distribution, metabolism, and excretion (ADME) studies. Materials and methods To model the interaction between myricetin and the target proteins (GCK, IR, and GSK3β), we used molecular docking analysis with computational tools. ADME studies were also included in the study to evaluate drug affinity. Identification of binding sites, essential residues, and interaction stability were all part of the structural analysis. Results As evidence of possible interactions with these regulatory proteins, myricetin showed positive binding affinities with GCK, IR, and GSK3β. Strong interactions with important ligand recognition residues were seen in the docking into IR, indicating a potential impact on insulin signalling. Moreover, a strong binding affinity for GCK indicated potential effects on the metabolism of glucose. Studies using ADME confirmed the high drug affinity of myricetin. Conclusion This work sheds light on the multi-target potential of myricetin in the regulation of diabetes. It appears that it has the ability to influence glucose metabolism, suppress GSK3β activity, and regulate insulin signalling based on its interactions with IR, GSK3β, and GCK. Although these computational results show promise, more experimental work is necessary to confirm and fully understand the precise mechanisms that underlie myricetin's effects on the regulation of diabetes.